SCHEMBL29326219

SCHEMBL29326219

Cc1ncccc1-c1cc2[nH]c(=O)n(-c3cccc4ccccc34)c(=O)c2s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.42
FEN1 P39748 1/20 0.42
ITGA4 P13612 2/20 0.38
ITGB7 P26010 2/20 0.38
HCAR1 Q9BXC0 1/20 0.38
BRD4 O60885 1/20 0.37
IDO1 P14902 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27377591 0.90 ERCC5 (0.38) ERCC5FEN1BRD4IDO1ALDH1A1
SCHEMBL29326216 0.88 ERCC5 (0.39) ERCC5FEN1ITGA4ITGB7HCAR1
SCHEMBL29326183 0.87 ERCC5 (0.43) ERCC5FEN1ITGA4ITGB7HCAR1
SCHEMBL29326188 0.85 CYP1A1 (0.53) ERCC5FEN1ITGA4ITGB7CYP1A2
SCHEMBL29326196 0.83 CYP1A1 (0.44) ERCC5FEN1ITGA4ITGB7HCAR1
SCHEMBL29326194 0.83 ERCC5 (0.40) ERCC5FEN1ITGA4ITGB7HCAR1
SCHEMBL29326162 0.83 CYP1A1 (0.53) ERCC5FEN1ITGA4ITGB7CYP1A2
SCHEMBL29326658 0.82 ERCC5 (0.39) ERCC5FEN1HCAR1IDO1CYP1A2
SCHEMBL29326328 0.82 IDO1 (0.41) FEN1ITGA4ITGB7HCAR1IDO1
SCHEMBL29326166 0.81 ERCC5 (0.60) ERCC5FEN1HCAR1CYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS ACE2, TMPRSS2, ACE ERCC5 2042/4885FEN1 1012/4885ITGA4 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.